Eris Lifesciences to acquire Oaknet Healthcare for Rs 650 crore

Mr Krishnakumar V, Executive Director & Chief Operating Officer of Eris Lifesciences Ltd., added, "The acquisition of Oaknet brings marquee brands like Cosvate and Cosmelite into the Eris portfolio."

Published On 2022-05-04 05:49 GMT   |   Update On 2022-05-04 06:44 GMT
Advertisement

Mumbai: Eris Lifesciences Limited, a Indian branded formulations manufacturing company, has announced its acquisition of a 100% stake in Mumbai-based dermatology focused domestic formulations company Oaknet Healthcare Pvt Ltd for a total consideration of Rs 650 crore (INR 6,500 mn).

The deal will be financed by INR 3,000 mn of internal accruals and INR 3,500 mn of borrowings.

Commenting on the acquisition, Mr. Amit Bakshi, Chairman & Managing Director of Eris Lifesciences Ltd., said, "As Oaknet becomes part of the Eris Group, it provides us with a robust growth platform in the areas of Dermatoloy and Cosmetology. In line with Strides and Zomelis acquisitions, we are confident that the Oaknet transaction will create long-term value for our shareholders."
Advertisement
Mr. Krishnakumar V, Executive Director & Chief Operating Officer of Eris Lifesciences Ltd., added, "The acquisition of Oaknet brings marquee brands like Cosvate and Cosmelite into the Eris portfolio. We expect to bring to bear multiple value creation levers including in-house manufacturing, new product launches, expansion of field force productivity and enhancement of operational efficiency."
The acquisition will be completed by way of a share purchase agreement as a result of which Oaknet will become a wholly owned subsidiary of Eris. 

With a revenue base of INR 1,950 million in FY22, Oaknet brings a well-established portfolio of leading brands in Dermatology and Women's Health to the Eris stable. Eris' Specialty Franchise will get a significant impetus with this acquisition with Eris now present in 87% of the INR 55,000 crore Chronic Market, with a significant presence in the major Chronic Therapies in the IPM – Cardiology, Oral diabetes care, Insulin, Neuro/CNS and Dermatology. Oaknet has near 100% coverage of approx. 11,000 Dermatologists across India with a 60% penetration and has a pan India sales and distribution presence.

Read also: Eris Lifesciences launches TruSaniz hand sanitizer; appoints Shilpa Shetty as brand ambassador

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News